Table 1.
Abbreviations
| 5aza | 5-Azacytidine | hm6A | N6-Hydroxymethyladenosine |
| 5azadC | 5-Aza-2-deoxycytidine | HMEC | Human microvascular endothelial cell |
| 5hMeC | 5-Hydroxymethylcytosine | HNRNP | Heterogeneous nuclear ribonucleoprotein |
| 5MeC | 5-Methylcytosine | HREC | Diabetic human retinal endothelial cell |
| ADK | Adenosine kinase | HSPC | Haematopoietic stem and progenitor cells |
| ALKBH5 | Alkylation repair homologue 5 | HUVEC | Human umbilical vein endothelial cell |
| AngII | Angiotensin II | ICAM | Intercellular adhesion molecule |
| C38 | Cytosine 38 | ICM | Ischaemic cardiomyopathy |
| CGI | CpG islands | IGF2BP1–3 | Insulin-like growth factor 2 mRNA-binding proteins 1–3 |
| CpG | Cytosine-(phosphate)-guanine dinucleotide | lncRNA | Long non-coding RNA |
| CRISPR | Clustered regularly interspaced short palindromic repeats | m5C | 5-Methylcytosine (RNA) |
| DCM | Dilated cardiomyopathy | m6A | N6-Methyladenosine |
| DNA | Deoxyribonucleic acid | MBD | Methyl-CpG-binding domain protein |
| DNMT | DNA methyltransferase | MCEC | Murine cerebral endothelial cell |
| DR | Diabetic retinopathy | MeCP | Methyl-CpG-binding protein |
| EC | Endothelial cell | METTL3 | Methyltransferase like 3 |
| ECFC | Endothelial colony-forming cell | MI | Myocardial infarction |
| ECM | Extracellular matrix | MMP | Matrix metalloproteinase |
| EDHF | Endothelium-dependent hyperpolarising factor | mRNA | Messenger RNA |
| EHT | Endothelial-haematopoietic transition | NO | Nitric oxide |
| eIF | Eukaryotic initiation factor | NSUN | NOL1/NOP2/sun domain |
| EndoMT | Endothelial to mesenchymal transition | PLAC | Placenta-associated |
| eNOS | Endothelial nitric oxide synthase | POLG | Polymerase γ-1 |
| EPCs | Endothelial progenitor cells | Pprc2a | Proline-rich coiled-coil 2A |
| ET-1 | Endothelin 1 | R7W-MP | Cell-penetrating mimetic peptides |
| EZH2 | Enhancer of zeste homologue 2 | RNA | Ribonucleic acid |
| f6A | N6-Formyladenosine | RNAi | RNA interference |
| FTO | Fat mass and obesity–associated protein | ROS | Reactive oxygen species |
| HCAEC | Human coronary artery macrovascular endothelial cells | rRNA | Ribosomal ribonucleic acid |
| HCMEC | Human coronary microvascular endothelial cells | SAM | S-Adenosylmethionine |
| HF | Heart failure | siRNA | Small interfering RNA |
| HFmrEF | HF mid-range ejection fraction | TAC | Transaortic constriction |
| HFpEF | HF with preserved ejection fraction | TET | Ten-eleven translocation |
| HFrEF | HF with reduced ejection fraction | TGFB2 | Transforming growth factor B2 |
| HIF | Hypoxia inducible factor | TNFα | Tumour necrosis factor alpha |
| hm5C | 5-Hydroxymethylcytosine (RNA) | tRNA | Transfer RNA |
| hm6A | N6-Hydroxymethyladenosine | Tsp-1 | Thrombospondin-1 |
| HMEC | Human microvascular endothelial cell | UTR | Untranslated terminal region |
| HNRNP | Heterogeneous nuclear ribonucleoprotein | VDAC1 | Voltage-dependent anion-selective channel 1 |
| HREC | Diabetic human retinal endothelial cell | VE | Vascular endothelial |
| HFpEF | HF with preserved ejection fraction | VEGF | Vascular endothelial growth factor |
| HFrEF | HF with reduced ejection fraction | vWF | Von Willebrand factor |
| HIF | Hypoxia inducible factor | WTAP1 | Wilms’ tumour-associated protein 1 |
| hm5C | 5-Hydroxymethylcytosine (RNA) | YTH | YT521-B homology |